about
Fluorescent labelling of cRNA for microarray applicationsNew methods for next generation sequencing based microRNA expression profilingMuscle regeneration in dystrophin-deficient mdx mice studied by gene expression profilingOveractive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophyGenetics of the human metabolome, what is next?Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levelsThe FAIR Guiding Principles for scientific data management and stewardshipDrug Repositioning through Systematic Mining of Gene Coexpression Networks in CancerSystematic identification of trans eQTLs as putative drivers of known disease associationsHuntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s diseaseLow dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout miceAccounting for immunoprecipitation efficiencies in the statistical analysis of ChIP-seq data.Joint modeling of ChIP-seq data via a Markov random field model.Determining the quality and complexity of next-generation sequencing data without a reference genome.Exploiting the full power of temporal gene expression profiling through a new statistical test: application to the analysis of muscular dystrophy dataConsistency of biological networks inferred from microarray and sequencing dataMicroarray retriever: a web-based tool for searching and large scale retrieval of public microarray dataCan subtle changes in gene expression be consistently detected with different microarray platforms?Relative power and sample size analysis on gene expression profiling data.Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor.Tissue-specific transcript annotation and expression profiling with complementary next-generation sequencing technologies.Systematic genomic and translational efficiency studies of uveal melanoma.Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy.Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophiesInterspecies translation of disease networks increases robustness and predictive accuracy.RNA sequencing: from tag-based profiling to resolving complete transcript structure.Phage display screening without repetitious selection rounds.PASSion: a pattern growth algorithm-based pipeline for splice junction detection in paired-end RNA-Seq data.Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA.The effects of low levels of dystrophin on mouse muscle function and pathologyTbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formationExploring the transcriptome of ciliated cells using in silico dissection of human tissues.Transcriptome and genome sequencing uncovers functional variation in humansAging as accelerated accumulation of somatic variants: whole-genome sequencing of centenarian and middle-aged monozygotic twin pairs.A promoter-level mammalian expression atlasAlternative mRNA transcription, processing, and translation: insights from RNA sequencing.DeepSAGE reveals genetic variants associated with alternative polyadenylation and expression of coding and non-coding transcripts.Antisense-oligonucleotide mediated exon skipping in activin-receptor-like kinase 2: inhibiting the receptor that is overactive in fibrodysplasia ossificans progressivaInsight in genome-wide association of metabolite quantitative traits by exome sequence analysesGeneric information can retrieve known biological associations: implications for biomedical knowledge discovery.
P50
Q24550727-618C765B-58D4-4FD0-897C-725CDBD72665Q24595144-1669C594-CE28-4EB5-9828-7BBDDC3A6B17Q24815340-E6116371-3B6A-4C88-B42A-18A8AF6DAB68Q26864900-6818D71B-6D9A-49E8-A717-BC39B536226EQ27006776-D22F34DB-97C5-43B2-A4D9-ECAC619B8BC8Q27324181-8696B471-18D7-43A9-9811-CA2D6462BC74Q27942822-1624eb9c-4105-0210-536a-7fda72a9742cQ28553245-DEE81AA8-89C0-4243-97B7-1CB5BC3F2E63Q28659854-33663781-13A9-4E24-9722-89790ED6C066Q29248581-38C36648-023A-4DC6-A859-8551E275EF98Q30539986-983442F4-0962-4AD8-8072-7946783C19C5Q30636277-B3DDF3C6-9C7F-4DCC-9664-F3FA85BAA2EFQ30687341-499A25D7-B000-4536-9C43-07A4327009B9Q30878849-D9AE0D53-F703-48BC-8CB9-6EC82F199802Q31035733-CE5472A3-89EC-4513-96B8-652B71AFB40AQ31110541-E04FD926-C017-4390-BA9E-7618BF26C83AQ31154699-4D79E7C5-5DD0-4E4A-A244-DC4F6F63F850Q33323244-D0B09E61-EDAF-4F2F-9158-3357D69B5D8DQ33503913-03467C72-1DF2-470E-AEE7-9EFBEE611CD3Q33570741-FE125F9A-F301-43C3-896B-F30BCBB274DEQ33628366-BB4F761B-AA74-4E7A-9FFF-65CB6FCE7864Q33778295-0D73BF10-83C8-4393-8886-0BDA03BE800EQ33877924-3AAAE670-F245-4AAD-BCB1-BE35F4A32A1DQ33991470-DB6E4307-BDF8-4185-8D01-1C0616C4CCA2Q34071347-F4C8C677-64FC-4373-9BD8-2625B828488DQ34085158-D713619A-F813-4027-8FBC-9B571786D154Q34104565-82D55783-E0BD-412E-8AA9-F625D50DF463Q34118889-F9CF20EE-E74F-41A0-91FD-17C5927B854DQ34132442-A843A311-154F-442B-9286-1BF8B8DE1EE0Q34168463-7AACCB35-2101-45D2-8D28-0B9127A1A162Q34237167-12D6496B-3A79-4069-B899-45EED6CC4D5EQ34256530-0046E775-A34B-4C45-B336-16DAC0AAFF9EQ34371227-FC820E58-C8B9-4257-8FFA-D26F13A74625Q34381942-92E52D4F-39B5-4A2A-8F97-3E6A935A2EA1Q34412203-C8536D36-8E83-4FA2-B2C7-5B2B9F8466F7Q34461131-8C7176D0-843B-4CC2-9385-971450DCB53BQ34789467-827595EA-847B-4400-A701-6CEBE18A581AQ34828364-663B3236-AADD-4B0A-A9C4-C1067E951F3AQ34872431-12737BBC-9E2F-4B3C-894D-07FC7CE629D2Q35048092-0FBA9A08-112F-4300-85ED-7753A6770B54
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter A.C. 't Hoen
@ast
Peter A.C. 't Hoen
@en
Peter A.C. 't Hoen
@es
Peter A.C. 't Hoen
@nl
type
label
Peter A.C. 't Hoen
@ast
Peter A.C. 't Hoen
@en
Peter A.C. 't Hoen
@es
Peter A.C. 't Hoen
@nl
altLabel
't Hoen PA
@en
P A C 't Hoen
@en
Peter 't Hoen
@en
Peter A 't Hoen
@en
Peter A C 't Hoen
@en
Peter A C T' Hoen
@en
Peter Ac 't Hoen
@en
Peter-Bram A C 't Hoen
@en
prefLabel
Peter A.C. 't Hoen
@ast
Peter A.C. 't Hoen
@en
Peter A.C. 't Hoen
@es
Peter A.C. 't Hoen
@nl
P1053
D-3950-2018
P106
P21
P2456
P31
P496
0000-0003-4450-3112